Geron - 25 Year Stock Price History | GERN

Historical daily share price chart and data for Geron since 1996 adjusted for splits. The latest closing stock price for Geron as of September 24, 2021 is 1.37.
  • The all-time high Geron stock closing price was 69.81 on March 01, 2000.
  • The Geron 52-week high stock price is 2.35, which is 71.5% above the current share price.
  • The Geron 52-week low stock price is 1.20, which is 12.4% below the current share price.
  • The average Geron stock price for the last 52 weeks is 1.60.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Geron Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 1.5238 1.6300 2.1000 1.2000 1.3700 -13.84%
2020 1.6010 1.3300 2.1900 0.8873 1.5900 16.91%
2019 1.4509 1.0400 2.0200 1.0100 1.3600 36.00%
2018 3.1055 1.8100 6.3800 0.9816 1.0000 -44.44%
2017 2.2923 2.1300 3.1000 1.8000 1.8000 -13.04%
2016 2.6491 4.5800 4.5800 1.8100 2.0700 -57.23%
2015 3.7528 3.3000 5.1200 2.6900 4.8400 48.92%
2014 2.9108 4.9000 5.7100 1.6900 3.2500 -31.43%
2013 2.2321 1.4900 5.8700 1.0200 4.7400 236.17%
2012 1.6500 1.5600 2.9000 1.0600 1.4100 -4.73%
2011 3.6176 5.2600 5.3600 1.3700 1.4800 -71.47%
2010 5.4846 6.2200 6.5700 4.5400 5.1875 -6.53%
2009 6.2070 4.8200 9.1700 3.7900 5.5500 18.84%
2008 4.2830 5.7300 5.7300 2.2300 4.6700 -17.78%
2007 7.4507 8.7600 9.4800 5.6800 5.6800 -35.31%
2006 7.4628 8.7000 9.5200 5.8700 8.7800 1.97%
2005 8.4428 7.7700 11.7400 5.6800 8.6100 8.03%
2004 7.8732 10.1040 11.8000 5.2300 7.9700 -20.06%
2003 7.2788 3.6100 16.1500 1.4100 9.9700 176.94%
2002 5.7149 8.5900 10.1500 3.4700 3.6000 -58.62%
2001 13.2391 14.8100 20.3100 8.2300 8.7000 -43.65%
2000 27.1971 13.0000 69.8100 13.0000 15.4400 22.25%
1999 10.9776 10.6300 14.8800 9.2500 12.6300 16.08%
1998 9.6997 8.5000 17.1900 4.2190 10.8800 31.88%
1997 10.1047 13.6300 18.0000 5.8750 8.2500 -37.74%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.465B $0.000B
Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71